Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Pieris Reports Amendment To Existing Immuno-oncology Multi-Target Collab With Seagen, $13M Strategic Investment By Seagen


Benzinga | Mar 25, 2021 08:03AM EDT

Pieris Reports Amendment To Existing Immuno-oncology Multi-Target Collab With Seagen, $13M Strategic Investment By Seagen






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC